Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Share-based Compensation (2018 - 2025)

Eton Pharmaceuticals' Share-based Compensation history spans 7 years, with the latest figure at $1.1 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 43.73% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 million, a 80.6% increase, with the full-year FY2025 number at $5.5 million, up 74.15% from a year prior.
  • Share-based Compensation hit $1.1 million in Q4 2025 for Eton Pharmaceuticals, up from $1.1 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ETON hit a ceiling of $2.1 million in Q2 2025 and a floor of $673000.0 in Q1 2021.
  • Historically, Share-based Compensation has averaged $960650.0 across 5 years, with a median of $867500.0 in 2021.
  • Biggest five-year swings in Share-based Compensation: plummeted 46.31% in 2023 and later skyrocketed 188.31% in 2025.
  • Tracing ETON's Share-based Compensation over 5 years: stood at $863000.0 in 2021, then increased by 2.67% to $886000.0 in 2022, then dropped by 15.35% to $750000.0 in 2023, then increased by 4.27% to $782000.0 in 2024, then soared by 43.73% to $1.1 million in 2025.
  • Business Quant data shows Share-based Compensation for ETON at $1.1 million in Q4 2025, $1.1 million in Q3 2025, and $2.1 million in Q2 2025.